1. Association between the presence of HLA-B*5701, HLA-DR7 and HLA-DQ3 and hypersensitivity to HIV-1 reverse transcriptase inhibitor abacavir;Mallal,2002
2. Prospective genetic screening decreases the incidence of abacavir hypersensitivity in the Western Australian HIV Cohort Study;Rauch,2006
3. A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection;Opravil,2002
4. Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection;Martinez,2003
5. Three-year follow-up of protease inhibitor-based regimen simplification in HIV-infected patients;Martinez,2007